{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:18:01Z","timestamp":1775337481387,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain that has caused the coronavirus disease 2019 (COVID-19) pandemic, has presented healthcare systems around the world with an unprecedented challenge. In locations with significant rates of viral transmission, social distancing measures and enforced \u2018lockdowns\u2019 are the new \u2018norm\u2019 as governments try to prevent healthcare services from being overwhelmed. However, with these measures have come important challenges for the delivery of existing services for other diseases and conditions. The clinical care of patients with pituitary disorders typically involves a multidisciplinary team, working in concert to deliver timely, often complex, disease investigation and management, including pituitary surgery. COVID-19 has brought about major disruption to such services, limiting access to care and opportunities for testing (both laboratory and radiological), and dramatically reducing the ability to safely undertake transsphenoidal surgery. In the absence of clinical trials to guide management of patients with pituitary disease during the COVID-19 pandemic, herein the Professional Education Committee of the Pituitary Society proposes guidance for continued safe management and care of this population.<\/jats:p>","DOI":"10.1007\/s11102-020-01059-7","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T07:02:46Z","timestamp":1592463766000},"page":"327-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic\u2014an international perspective"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1955-4957","authenticated-orcid":false,"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-035X","authenticated-orcid":false,"given":"Justin S.","family":"Cetas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1731-2927","authenticated-orcid":false,"given":"Pouneh K.","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3654-9877","authenticated-orcid":false,"given":"Susana M.","family":"Mallea-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-6832","authenticated-orcid":false,"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-5566","authenticated-orcid":false,"given":"Ann","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-7839","authenticated-orcid":false,"given":"Maria M.","family":"Pineyro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4154-6547","authenticated-orcid":false,"given":"Luis V.","family":"Syro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-607X","authenticated-orcid":false,"given":"Nicholas A.","family":"Tritos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-392X","authenticated-orcid":false,"given":"Hani J.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"1059_CR1","unstructured":"WHO (2009) Pandemic influenza preparedness and response. WHO guidance document. https:\/\/www.who.int\/influenza\/resources\/documents\/pandemic_guidance_04_2009\/en\/. Accessed 30 Apr 2020"},{"key":"1059_CR2","unstructured":"WHO (2007) WHO Pandemic Phase Description and Main Actions by Phase. https:\/\/www.who.int\/influenza\/resources\/documents\/pandemic_phase_descriptions_and_actions.pdf. Accessed 30 Apr 2020"},{"key":"1059_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101664","author":"Z Lei","year":"2020","unstructured":"Lei Z, Cao H, Jie Y, Huang Z, Guo X, Chen J, Peng L, Cao H, Dai X, Liu J, Li X, Zhu J, Xu W, Chen D, Gao Z, He JR, Lin BL (2020) A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan China. Travel Med Infect Dis. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101664","journal-title":"Travel Med Infect Dis"},{"key":"1059_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa157","author":"C Iorio-Morin","year":"2020","unstructured":"Iorio-Morin C, Hodaie M, Sarica C, Dea N, Westwick HJ, Christie SD, McDonald PJ, Labidi M, Farmer JP, Brisebois S, D'Aragon F, Carignan A, Fortin D (2020) Letter: the risk of COVID-19 Infection during neurosurgical procedures: a review of severe acute respiratory distress syndrome Coronavirus 2 (SARS-CoV-2) modes of transmission and proposed neurosurgery-specific measures for mitigation. Neurosurgery. https:\/\/doi.org\/10.1093\/neuros\/nyaa157","journal-title":"Neurosurgery"},{"key":"1059_CR5","doi-asserted-by":"publisher","DOI":"10.3171\/2020.4.jns201031","author":"M Bernstein","year":"2020","unstructured":"Bernstein M (2020) Editorial. Neurosurgical priority setting during a pandemic: COVID-19. J Neurosurg. https:\/\/doi.org\/10.3171\/2020.4.jns201031","journal-title":"J Neurosurg"},{"key":"1059_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa116","author":"JF Burke","year":"2020","unstructured":"Burke JF, Chan AK, Mummaneni V, Chou D, Lobo EP, Berger MS, Theodosopoulos PV, Mummaneni PV (2020) Letter: the Coronavirus Disease 2019 global pandemic: a neurosurgical treatment algorithm. Neurosurgery. https:\/\/doi.org\/10.1093\/neuros\/nyaa116","journal-title":"Neurosurgery"},{"issue":"2","key":"1059_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3171\/2018.4.jns172148","volume":"131","author":"JH Kim","year":"2018","unstructured":"Kim JH, Dho YS, Kim YH, Lee JH, Lee JH, Hong AR, Shin CS (2018) Developing an optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas. J Neurosurg 131(2):500\u2013506. https:\/\/doi.org\/10.3171\/2018.4.jns172148","journal-title":"J Neurosurg"},{"key":"1059_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-020-04396-5","author":"A Kolias","year":"2020","unstructured":"Kolias A, Tysome J, Donnelly N, Sharma R, Gkrania-Klotsas E, Budohoski K, Karcheva S, Adapa R, Lawes I, Gurnell M, Hutchinson P, Bance M, Axon P, Santarius T, Mannion RJ (2020) A safe approach to surgery for pituitary and skull base lesions during the COVID-19 pandemic. Acta Neurochir (Wien). https:\/\/doi.org\/10.1007\/s00701-020-04396-5","journal-title":"Acta Neurochir (Wien)"},{"key":"1059_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa139","author":"DYC Chan","year":"2020","unstructured":"Chan DYC, Chan DTM, Mak WK, Wong GKC, Poon WS (2020) Letter: rongeurs, neurosurgeons, and COVID-19: how do we protect health care personnel during neurosurgical operations in the midst of aerosol-generation from high-speed drills? Neurosurgery. https:\/\/doi.org\/10.1093\/neuros\/nyaa139","journal-title":"Neurosurgery"},{"issue":"1","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","volume":"5","author":"A Colao","year":"2019","unstructured":"Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R (2019) Acromegaly. Nat Rev Dis Primers 5(1):20. https:\/\/doi.org\/10.1038\/s41572-019-0071-6","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"1059_CR11","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine S (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1059_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159(2):89\u201395. https:\/\/doi.org\/10.1530\/EJE-08-0267","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552\u2013561. https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat Rev Endocrinol"},{"key":"1059_CR14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Ioachimescu A, Katznelson L, Kelestimur F, Kopchick J, Krsek M, Lamberts S, Losa M, Luger A, Maffei P, Marazuela M, Mazziotti G, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn S, PuigDomingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, Van der Lely AJ, Wass J, Zatelli MC, Melmed S (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz096","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2018","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2018) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268\u2013332. https:\/\/doi.org\/10.1210\/er.2018-00115","journal-title":"Endocr Rev"},{"issue":"2","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/eje-18-0682","volume":"180","author":"AG Ioachimescu","year":"2019","unstructured":"Ioachimescu AG, Fleseriu M, Hoffman AR, Vaughan Iii TB, Katznelson L (2019) Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. Eur J Endocrinol 180(1):31\u201340. https:\/\/doi.org\/10.1530\/eje-18-0682","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382(10):937\u2013950. https:\/\/doi.org\/10.1056\/NEJMra1810772","journal-title":"N Engl J Med"},{"key":"1059_CR19","doi-asserted-by":"publisher","DOI":"10.1530\/eje-20-0352","author":"J Newell-Price","year":"2020","unstructured":"Newell-Price J, Nieman L, Reincke M, Tabarin A (2020) Endocrinology in the time of COVID-19: management of Cushing's syndrome. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-20-0352","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A (2015) Treatment of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807\u20132831. https:\/\/doi.org\/10.1210\/jc.2015-1818","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1059_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40265-019-01128-7","volume":"79","author":"JM Hinojosa-Amaya","year":"2019","unstructured":"Hinojosa-Amaya JM, Cuevas-Ramos D, Fleseriu M (2019) Medical management of Cushing's syndrome: current and emerging treatments. Drugs 79(9):935\u2013956. https:\/\/doi.org\/10.1007\/s40265-019-01128-7","journal-title":"Drugs"},{"issue":"5","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/joim.12975","volume":"286","author":"NA Tritos","year":"2019","unstructured":"Tritos NA, Biller BMK (2019) Current management of Cushing's disease. J Intern Med 286(5):526\u2013541. https:\/\/doi.org\/10.1111\/joim.12975","journal-title":"J Intern Med"},{"issue":"2","key":"1059_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1210\/jc.2012-3362","volume":"98","author":"L Onnestam","year":"2013","unstructured":"Onnestam L, Berinder K, Burman P, Dahlqvist P, Engstrom BE, Wahlberg J, Nystrom HF (2013) National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 98(2):626\u2013635. https:\/\/doi.org\/10.1210\/jc.2012-3362","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/eje-16-1029","volume":"177","author":"A Tjornstrand","year":"2017","unstructured":"Tjornstrand A, Nystrom HF (2017) Diagnosis of endocrine disease: diagnostic approach to TSH-producing pituitary adenoma. Eur J Endocrinol 177(4):R183\u2013r197. https:\/\/doi.org\/10.1530\/eje-16-1029","journal-title":"Eur J Endocrinol"},{"key":"1059_CR25","volume-title":"Encyclopedia of endocrine diseases","author":"O Koulouri","year":"2019","unstructured":"Koulouri O, Moran G (2019) TSH-secreting pituitary adenomas. In: Huhtaniemi I, Diana Anderson ML (eds) Encyclopedia of endocrine diseases. Elsevier Ltd., Oxford"},{"issue":"6","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.beem.2013.10.003","volume":"27","author":"O Koulouri","year":"2013","unstructured":"Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M (2013) Pitfalls in the measurement and interpretation of thyroid function tests. Best practice & research. Clin Endocrinol Metab 27(6):745\u2013762. https:\/\/doi.org\/10.1016\/j.beem.2013.10.003","journal-title":"Clin Endocrinol Metab"},{"issue":"6","key":"1059_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2265.2011.04023.x","volume":"74","author":"M Gurnell","year":"2011","unstructured":"Gurnell M, Halsall DJ, Chatterjee VK (2011) What should be done when thyroid function tests do not make sense? Clin Endocrinol (Oxf) 74(6):673\u2013678. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04023.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1059_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.beem.2009.05.006","volume":"23","author":"P Beck-Peccoz","year":"2009","unstructured":"Beck-Peccoz P, Persani L, Mannavola D, Campi I (2009) Pituitary tumours: TSH-secreting adenomas. Best practice & research. Clin Endocrinol Metab 23(5):597\u2013606. https:\/\/doi.org\/10.1016\/j.beem.2009.05.006","journal-title":"Clin Endocrinol Metab"},{"issue":"11","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"key":"1059_CR30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN (2020) Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2007621","journal-title":"N Engl J Med"},{"issue":"8","key":"1059_CR31","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/ndt\/gfq067","volume":"25","author":"M Darmon","year":"2010","unstructured":"Darmon M, Timsit JF, Francais A, Nguile-Makao M, Adrie C, Cohen Y, Garrouste-Orgeas M, Goldgran-Toledano D, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Souweine B, Azoulay E (2010) Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant 25(8):2510\u20132515. https:\/\/doi.org\/10.1093\/ndt\/gfq067","journal-title":"Nephrol Dial Transplant"},{"key":"1059_CR32","doi-asserted-by":"publisher","DOI":"10.1530\/eje-20-0361","author":"W Arlt","year":"2020","unstructured":"Arlt W, Baldeweg SE, Pearce SHS, Simpson HL (2020) Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-20-0361","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-020-01059-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:45:35Z","timestamp":1623973535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-020-01059-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01059-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"18 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MF has received research support to OHSU as principal investigator from Chiasma, Crinetics, Ionis, Novartis, Strongbridge and has received occasional scientific consulting from Chiasma, Crinetics, Ionis, Novo Nordisk, Novartis, Pfizer, Strongbridge. MB, JSC, PKF, SMM-G, MG, AM, MMP, LVS declares that they have no conflict of interest. NAT has received institution-directed research support from Ipsen and Novartis and has received occasional consulting fees from Novo Nordisk and Strongbridge. HJM is supported by the Wellcome\/EPSRC Centre for Interventional and Surgical Sciences (WEISS) and the NIHR BRC Neuro-oncology","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human subjects or animals performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}}]}}